M.A. Witlox

707 total citations
21 papers, 555 citations indexed

About

M.A. Witlox is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, M.A. Witlox has authored 21 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in M.A. Witlox's work include Virus-based gene therapy research (6 papers), Hip disorders and treatments (5 papers) and Orthopaedic implants and arthroplasty (4 papers). M.A. Witlox is often cited by papers focused on Virus-based gene therapy research (6 papers), Hip disorders and treatments (5 papers) and Orthopaedic implants and arthroplasty (4 papers). M.A. Witlox collaborates with scholars based in Netherlands, United States and Taiwan. M.A. Witlox's co-authors include Gertjan J.L. Kaspers, Jantine PosthumaDeBoer, Barend J. van Royen, P. Wuisman, Victor W. van Beusechem, Winald R. Gerritsen, Pieter E. Postmus, Anne‐Marie C. Dingemans, Giuseppe Giaccone and Roland A. L. M. Stallaert and has published in prestigious journals such as British Journal of Cancer, Molecular Cancer and Bone.

In The Last Decade

M.A. Witlox

20 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.A. Witlox Netherlands	13	312	165	122	111	96	21	555
Huajia Zhang United States	10	322 1.0×	338 2.0×	58 0.5×	106 1.0×	64 0.7×	11	766
Hongsheng Yang China	14	226 0.7×	85 0.5×	98 0.8×	87 0.8×	113 1.2×	32	503
Nobuyuki Kusaka Japan	14	222 0.7×	195 1.2×	174 1.4×	134 1.2×	34 0.4×	27	564
Kohei Okuyama Japan	14	202 0.6×	197 1.2×	37 0.3×	58 0.5×	56 0.6×	41	494
Jun‐Hyuk Choi South Korea	13	384 1.2×	74 0.4×	48 0.4×	64 0.6×	95 1.0×	26	593
Masashi Tomisawa Japan	10	286 0.9×	178 1.1×	32 0.3×	128 1.2×	143 1.5×	11	486
Neil McGowan United Kingdom	13	294 0.9×	238 1.4×	109 0.9×	34 0.3×	31 0.3×	30	664
Grazia Abou‐Ezzi United States	10	314 1.0×	138 0.8×	51 0.4×	28 0.3×	53 0.6×	13	614
Kannan Karuppaiah United States	10	322 1.0×	94 0.6×	89 0.7×	19 0.2×	65 0.7×	10	506
Katerina Kachler Germany	13	232 0.7×	187 1.1×	22 0.2×	53 0.5×	83 0.9×	16	612

Countries citing papers authored by M.A. Witlox

Since Specialization

Citations

This map shows the geographic impact of M.A. Witlox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Witlox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Witlox more than expected).

Fields of papers citing papers by M.A. Witlox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Witlox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Witlox. The network helps show where M.A. Witlox may publish in the future.

Co-authorship network of co-authors of M.A. Witlox

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Witlox. A scholar is included among the top collaborators of M.A. Witlox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Witlox. M.A. Witlox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moerman, Sophie, et al.. (2024). GUIDANCE study: guided growth of the proximal femur to prevent further hip migration in patients with cerebral palsy—study protocol for a multicentre randomised controlled trial. BMJ Open. 14(12). e091073–e091073.

Witlox, M.A., et al.. (2023). Strategies to optimize the information provision for parents of children with developmental dysplasia of the hip. Bone & Joint Open. 4(7). 496–506. 3 indexed citations

Hermus, Joris P.S., Sander M. J. van Kuijk, M.A. Witlox, et al.. (2023). Does anxiety influence outcome measurements in ankle replacement patients?. Foot and Ankle Surgery. 30(3). 231–238. 1 indexed citations

Marcellis, Rik, Rachel Senden, Paul Willems, et al.. (2023). Functional electrical stimulation during walking in children with unilateral spastic cerebral palsy: A randomized cross‐over trial. Developmental Medicine & Child Neurology. 66(5). 598–609. 2 indexed citations

Mathijssen, Nina M.C., et al.. (2022). Active monitoring versus immediate abduction as treatment of stable developmental dysplasia of the hip: a systematic review of the literature. BMJ Open. 12(9). e057906–e057906. 2 indexed citations

Hermus, Joris P.S., et al.. (2022). Complications following total ankle arthroplasty: A systematic literature review and meta-analysis. Foot and Ankle Surgery. 28(8). 1183–1193. 17 indexed citations

Marcellis, Rik, Paul Willems, Lucianne Speth, et al.. (2022). A randomized crossover study of functional electrical stimulation during walking in spastic cerebral palsy: the FES on participation (FESPa) trial. BMC Pediatrics. 22(1). 37–37. 9 indexed citations

Bergen, Christiaan J. A. van, Pieter Bas de Witte, Bart J. Burger, et al.. (2022). Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1. EFORT Open Reviews. 7(7). 498–505. 6 indexed citations

Witte, Pieter Bas de, Christiaan J. A. van Bergen, Yvon M den Hartog, et al.. (2022). Treatment of decentered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 2. EFORT Open Reviews. 7(8). 542–553. 4 indexed citations

10.

Hermus, Joris P.S., Sander M. J. van Kuijk, M.A. Witlox, et al.. (2021). Risk factors for total ankle arthroplasty failure: A Dutch Arthroplasty Register study. Foot and Ankle Surgery. 28(7). 883–886. 19 indexed citations

11.

Willems, P, et al.. (2017). Gait analysis and functional outcome in patients after Lisfranc injury treatment. Foot and Ankle Surgery. 24(6). 535–541. 18 indexed citations

12.

PosthumaDeBoer, Jantine, M.A. Witlox, Gertjan J.L. Kaspers, & Barend J. van Royen. (2011). Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clinical & Experimental Metastasis. 28(5). 493–503. 161 indexed citations

13.

Graat, Harm C.A., Victor W. van Beusechem, Frederik H.E. Schagen, et al.. (2008). Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases. Molecular Cancer. 7(1). 9–9. 15 indexed citations

14.

Witlox, M.A., Martine L.M. Lamfers, P. Wuisman, David T. Curiel, & Gene P. Siegal. (2007). Evolving gene therapy approaches for osteosarcoma using viral vectors: Review. Bone. 40(4). 797–812. 38 indexed citations

15.

Graat, Harm C.A., M.A. Witlox, Frederik H.E. Schagen, et al.. (2006). Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin. British Journal of Cancer. 94(12). 1837–1844. 37 indexed citations

16.

Oosterhoff, Dinja, H. M. Pinedo, M.A. Witlox, et al.. (2005). Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdΔ24. Gene Therapy. 12(12). 1011–1018. 19 indexed citations

17.

Heideman, Daniëlle A.M., Victor W. van Beusechem, Elisabeth Bloemena, et al.. (2004). Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus‐mediated expression of NK4. The Journal of Gene Medicine. 6(3). 317–327. 36 indexed citations

18.

Oosterhoff, Dinja, M.A. Witlox, Victor W. van Beusechem, et al.. (2003). Gene-directed enzyme prodrug therapy for osteosarcoma: sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2.. PubMed. 2(8). 765–71. 19 indexed citations

19.

Witlox, M.A., Victor W. van Beusechem, Jacques Grill, et al.. (2002). Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma. The Journal of Gene Medicine. 4(5). 510–516. 46 indexed citations

20.

Dingemans, Anne‐Marie C., M.A. Witlox, Roland A. L. M. Stallaert, et al.. (1999). Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.. PubMed. 5(8). 2048–58. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact